INTELLIGENCE IN ACTION

New York Takes the Lead in EPCS

February 01, 2016

NY State EPCS infogram_LI_1064x800 (1)Today, Surescripts released new data about its Electronic Prescribing of Controlled Substances (EPCS) solution, and how it’s helping New York tackle prescription drug abuse. In fact, prescribers in New York are adopting EPCS at five times the national rate of 5.8 percent. New York’s prescribers are embracing EPCS, and 27 percent of total prescribers are enabled to digitally prescribe controlled substances.

Surescripts’ Ken Whittemore, Senior Vice President of Professional and Regulatory Affairs, said, “Physicians in New York have done a really nice job in preparing for this change. Pharmacies have stepped up in a very big way as well. New York’s impressive adoption rate shows its healthcare community’s commitment to not only meeting the I-STOP mandate, but also recognizing one of the state’s most pressing and alarming healthcare challenges.”

I-STOP is the Internet System for Tracking Over-Prescribing (I-STOP) mandate, which requires that all prescriptions be transmitted electronically in New York by March 27, 2016.

The mandate, which was previously slated for March 27 of last year, was delayed due to political and industry concerns, as well as the Long Term Care market’s sense of unpreparedness.

Whittemore is hopeful that the gap in adoption will close quickly, especially as the steps to comply are similar to other processes physicians and pharmacies regularly deal with.

“There’s still time to implement and adopt EPCS, “said Whittemore. “It certainly takes a bit of work for prescribers to complete identity proofing and credentialing, but the process isn’t all that different from others in terms of time and effort. And the great part is, once it’s done, it’s done.”

Visit getEPCS.com to review the steps to enabling the electronic transmission of controlled substance prescriptions. 

Related Articles

January 02, 2019

Laws Requiring the E-Prescribing of Opioids Have Gained Momentum, but Prescriber Adoption is Playing Catch Up

The SUPPORT for Patients and Communities Act, which Congress passed and President Trump signed into law in October, mandates the use of electronic prescribing of controlled substances (EPCS) for all controlled substances under Medicare Part D by January 1, 2021.

Read more...
October 24, 2018

Surescripts Applauds New Law to Drive Adoption of Technology to Combat the Opioid Epidemic

Surescripts commends Congress for passing and President Trump for signing H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act into law on October 24, 2018. This law will support the broader adoption of existing technology that can help deter prescription fraud, diversion and abuse. Today marks a major milestone in our efforts to combat the opioid epidemic and save lives. Read more...
July 05, 2018

Key Technologies for Fighting Opioid Misuse are Gaining Traction

The statistics are staggering. According to the Centers for Disease Control and Prevention, the opioid epidemic now takes more lives in the U.S. than breast cancer. In addition, American life expectancy at birth declined for the second consecutive year in 2016 due to a dramatic 21 percent rise in the death rate from drug overdoses. Our nation has not experienced a two-year consecutive decline in life expectancy since the early 1960s as a result of an influenza epidemic. Even the worst mortality rate of the AIDS epidemic in 1993 caused American life expectancy to drop for just one year. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX